Optimer Posts Wider LossZacks.comThe company initiated a phase IIIb study evaluating the prophylactic use of Dificid in patients undergoing bone marrow transplantation (BMT) or hematopoietic stem cell transplant (HSCT). Optimer also plans to initiate a…
India staring at killer lifestyle epidemic – Hindustan Times
 Hindustan Times |
India staring at killer lifestyle epidemic
Hindustan Times “The menace of heart disease, stroke, diabetes, lung disease, depression, and road injuries is mounting in the form of premature deaths and disability,” said Dr Srinath Reddy, president, Public Health Foundation of India. “Much of this is avoidable … Window in kitchen can prevent millions of deathsDeccan Herald New data show countries around the world grappling with changing health …Medical Xpress |
Charity briefs for March 5 – SouthtownStar
|
Charity briefs for March 5
SouthtownStar Josie’s Day: Several local restaurants are combining to raise funds for Josie Nordman, a Homewood teen who is awaiting a lung transplant. On “Josie’s Day,” each Wednesday during March, diners can visit one of four restaurants and receive 10 percent off … |
Window in kitchen can prevent millions of deaths – Deccan Herald
Window in kitchen can prevent millions of deathsDeccan HeraldHousehold air pollution generated from burning coal cow-dung cake, wood and farm residue as cooking fuel inside poorly ventilated kitchen kills women who first developed lung diseases which s…
Disease Status May Be Key To Outcome Of Second Stem Cell Transplant In … – The Myeloma Beacon
Disease Status May Be Key To Outcome Of Second Stem Cell Transplant In …The Myeloma BeaconResults of a retrospective British study add to the body of research indicating that a second stem cell transplant can be effective salvage therapy for certain …
Son's pending stem cell transplant leaves parents strapped – Crestview News Bulletin
|
Son’s pending stem cell transplant leaves parents strapped
Crestview News Bulletin “That’s why we are going through with the stem cell transplant.” In May, the small brown-haired boy will undergo transplant surgery that will enable him to attend public school, play football and live a relatively normal life for a person with an … |
China and the mirror of history – The Economist (blog)
 The Economist (blog) |
China and the mirror of history
The Economist (blog) … economist is on a roll this week. The week just started and they needed by put up 4 “How bad China is” articles. May I suggest an encore on Tibet, Fa Lung Gung, and a conspiracy theory on how chinese drink the blood of white babies while exporting … |
Everolimus approval now includes prevention of liver transplant rejection – Clinical Endocrinology News Digital Network
Everolimus approval now includes prevention of liver transplant rejectionClinical Endocrinology News Digital NetworkThe approved indication states that in liver transplant recipients, everolimus is used in combination with the calcineurin inhibitor tac…
India board rules against Bayer in cancer drug patent case – Reuters
 The National Law Journal |
India board rules against Bayer in cancer drug patent case
Reuters Announcing the decision, Justice Prabha Sridevan said the kidney and liver cancer drug should be available at an affordable price to everybody. Bayer said in a statement it “strongly disagreed” with the conclusions of the board, adding that it would … India Patent Ruling on Cancer Drug a Blow to Bayer AGThe National Law Journal India Appeals Body Rejects Bayer’s Plea on NexavarWall Street Journal (India) Bayer to Appeal India Ruling That Allows Copy of Cancer DrugBloomberg Economic Times –Intellectual Property Watch –MSF UK (press release) all 19 news articles » |
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market … – PR Newswire (press release)
|
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market …
PR Newswire (press release) GBI Research, the leading business intelligence provider, has released its latest research, “Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion”. |